Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F9DG7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $75,998
Award facts
- Contract value 100% obligated
- $75,998.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $75,998.24 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, a specialty pharmaceutical product used in cardiovascular disease management. This firm fixed-price delivery order, issued on November 26, 2025, with completion targeted for November 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award carries no set-aside designation, indicating it was competitively awarded to this major pharmaceutical distributor. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive contract portfolio demonstrates capability in delivering a comprehensive range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. As the prime vendor under the SPE2DX global pharmaceutical support vehicle, AmerisourceBergen is positioned to supply medical commodities to customers including the Defense Health Agency and U.S. Coast Guard, with this delivery order exemplifying the company's role in fulfilling specialized pharmaceutical requirements for federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9DG7?
SPE2DR26F9DG7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26F9DG7 worth?
The government has obligated $75,998 on SPE2DR26F9DG7.
Is contract SPE2DR26F9DG7 an order under another contract?
Yes. SPE2DR26F9DG7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9DG7 competed?
The extent of competition for SPE2DR26F9DG7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award